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Understanding the biological fate of graphene-based materials
such as graphene oxide (GO) is crucial to assess adverse effects
following intentional or inadvertent exposure. Here we provide
first evidence of biodegradation of GO in the gastrointestinal tract
using zebrafish as a model. Raman mapping was deployed to
assess biodegradation. The degradation was blocked upon knock-
down of nos2a encoding the inducible nitric oxide synthase (iNOS)
or by pharmacological inhibition of NOS using L-NAME, demon-
strating that the process was nitric oxide (NO)-dependent. NO-
dependent degradation of GO was further confirmed in vitro by
combining a superoxide-generating system, xanthine/xanthine
oxidase (X/XO), with an NO donor (PAPA NONOate), or by simul-
taneously producing superoxide and NO by decomposition of
SIN-1. Finally, by using the transgenic strain Tg(mpx:eGFP) to visu-
alize the movement of neutrophils, we could show that inhibition
of the degradation of GO resulted in increased neutrophil infiltra-
tion into the gastrointestinal tract, indicative of inflammation.
Graphene and its derivatives have been intensively explored for
a multitude of biomedical and other applications. This, there-
fore, mandates a comprehensive assessment of the potential
impact of these materials on human health.1 In recent years,
attention has been focused on the biological fate of graphene-
based materials, including their potential biodegradability.
Thus, enzymatic degradation of graphene oxide (GO) by plant
and animal peroxidases, including myeloperoxidase (MPO),
has been documented.2,3 Purified human MPO was shown to
degrade highly dispersed GO, but failed to metabolize aggre-
gated GO.3 Furthermore, we demonstrated in a previous study
that primary human neutrophils are capable of degrading GO
when activated to undergo degranulation with release of
MPO,4 while GO functionalized with a chemotactic peptide
triggered neutrophil activation with subsequent degradation of
GO.5 Single- and few-layer graphene is also susceptible to enzy-
matic degradation though the process was found to be less
efficient as compared to GO.6
Previous studies on single- and multi-walled carbon nano-
tubes (CNTs) have revealed the propensity of these materials to
undergo peroxidase-mediated biodegradation.7–10 Furthermore,
CNTs may also undergo peroxynitrite (ONOO−) dependent
biodegradation in macrophages11,12 and chondrocytes.13
Peroxynitrite can be generated by the rapid reaction of super-
oxide radicals with nitric oxide (NO) according to the following
reaction:
O2• þ NO• ! ONOO
The peroxynitrite anion produced in this manner displays
high diffusibility,14 obviating the need for a direct interaction
of CNTs with the participating enzymes.11 However, no study
has been conducted to investigate the possibility of NO-driven
biodegradation of GO. Here we studied GO produced by the
Hummers’ method to investigate the in vitro and in vivo
degradability. The physicochemical characterization results are
summarized in Table S1.† Based on the evaluation of GO by
TEM, SEM, optical microscopy and AFM, we found that 90% of
the sheets ranged between 0.1 to 15 µm in lateral dimensions
(representative TEM images are shown in Fig. 1a). AFM ana-
lysis revealed that the thickness of the GO sheets was between
1 to 2 nm, allowing us to conclude that GO was mainly present
as single- or few-layer sheets in water and after incubation for
24 h in E3 medium (Fig. 1b and c). Note that the spikes in
thickness following incubation in E3 medium are due to
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wrinkling and folding of GO sheets as a result of incubation in
a high salt containing medium.
Inhalation is the main route of unintentional exposure to
engineered nanomaterials, and the lungs therefore represent
the most immediate target organ for their toxic effects.
However, extrapulmonary effects of inhaled nanomaterials
including effects on the gastrointestinal (GI) tract have been
reported; additionally, nanomaterials can be ingested leading to
a direct exposure of the GI tract.15 Despite the potential impli-
cations on human health, the impact of nanomaterials on the
GI tract has been largely overlooked.16 We focused here on oral
exposure to GO. It is well known that NO is produced in the GI
tract through enzymatic and non-enzymatic reactions,17 and we
hypothesized that GO may undergo NO-dependent bio-
degradation (Fig. 2a). To address this question, we used zebra-
fish embryos that have emerged in recent years as a robust
in vivo model in toxicology and drug discovery.18 The degra-
dation of GO in zebrafish larvae (5 days postfertilization, dpf)
was evaluated using confocal Raman mapping. To investigate
the mechanism of biodegradation of GO in the GI tract, we
employed two approaches: (i) downregulation of the inducible
NO synthase (iNOS) by using morpholino oligonucleotides
directed against nos2a; and (ii) inhibition of NOS by using the
cell-permeable inhibitor, N-omega-nitro-L-arginine methyl ester
hydrochloride (L-NAME). The successful downregulation of
nos2a was documented by RT-qPCR (Fig. 2b). As demonstrated
in Fig. 2c, GO accumulated in the GI tract and could be detected
on the basis of its characteristic Raman signature, i.e., the D
band (1354 cm−1), G band (1582 cm−1), and 2D band
(2690 cm−1).19 The background signal of the fish tissues did not
interfere with the detection of GO by Raman (data not shown).
Importantly, our interventions (shown schematically in Fig. 2a)
resulted in a pronounced change in the intensity of the D and G
band when compared to untreated, GO-exposed fish, indicating
that GO was biodegraded in the latter case through an NO-
dependent mechanism (Fig. 2d). It is worth noting that a pre-
vious study showed no degradation of GO when immersed in
simulated digestive juices representative of the GI tract, as eval-
uated by Raman analysis.20 This allows us to rule out a role of
gastrointestinal fluids in the degradation of GO.
Fig. 1 Structural characterization of GO sheets after incubation in E3 medium versus water using transmission electron microscopy (TEM) (a) and
atomic force microscopy (AFM) (b) height image and (c) cross section analysis highlighted by the line in the height image.
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To support the role of NO in the biodegradation process, we
measured NO production in vivo by using the fluorescent
probe, DAF-FM-DA. Bacterial lipopolysaccharide (LPS) was
used to trigger NO production (Fig. 3a). NO production was
suppressed by L-NAME (Fig. 3b). Exposure to GO also led to an
increase in NO (Fig. 3b). Importantly, knockdown of nos2a
with morpholino oligos resulted in a decline in LPS- and GO-
induced NO production (Fig. 3b; representative images of zeb-
rafish embryos are shown in panel a). We also detected peroxy-
nitrite generation in vivo by using DAX-J2 PON Green, a fluo-
rescent probe with high selectivity for peroxynitrite and negli-
gible reactivity with other relevant species including NO.
Peroxynitrite production was observed in vivo in response to
GO and to a lesser extent with LPS and the signal was sup-
pressed by L-NAME (Fig. S1†).
To further confirm the degradation of GO and provide more
insight regarding the NO-dependent reaction, we performed
in vitro experiments by using two peroxynitrite-generating
systems, i.e., simultaneous production of superoxide radicals
and NO by decomposition of 3-morpholinosydnonimine
hydrochloride (SIN-1), or the combination of a superoxide-gen-
erating system, xanthine/xanthine oxidase (X/XO), with an NO
donor (PAPA NONOate).11 As shown in Fig. 4a, GO degradation
after 5 days of continuous incubation in the presence of SIN-1
or PAPA NONOate-X/XO was visually detectable as the suspen-
sions turned translucent in both cases. To more objectively
document the degradation, we performed Raman spec-
troscopy. The characteristic D and G bands of GO were remark-
ably diminished in both systems suggesting a near-complete
loss of structure of GO (Fig. 4b). The topography and structure
of GO incubated with the two peroxynitrite-generating systems
was further characterized by TEM (Fig. 4c) and AFM (Fig. 4d).
Specifically, after PAPA NONOate-X/XO treatment, the typical
morphology of the GO sheets disappeared, and only small frag-
Fig. 2 NO-dependent biodegradation of GO in vivo. (a) Schematic diagram showing the generation of nitric oxide (NO) by iNOS followed by the
reaction of superoxide radicals and NO to form the potent oxidant, peroxynitrite. (b) Relative mRNA expression level of nos2a following knockdown
of nos2a. (c) Raman confocal mapping of GO in zebrafish. GO was found to accumulate in the gut upon oral exposure, as demonstrated by optical
and Raman confocal images. (d) Zebrafish larvae at 5 dpf were exposed to GO at 5 µg mL−1 for 24 h. Morpholino oligonucleotides (MO) were
injected into one-cell stage zebrafish embryos to downregulate nos2a expression. L-NAME was used to inhibit NOS in conventional fish. Each spec-
trum represents the average of 10.000 spectra across the whole area scan.
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Fig. 3 NO production in zebrafish. (a) Representative fluorescence images of NO production in zebrafish gut, represented as the corrected gut flu-
orescence determined by DAF-FM-DA assay. The gut is indicated by the white dashed line. (b) Quantification of NO production determined by
DAF-FM-DA assay. NO production was induced by LPS and GO, while L-NAME and downregulation of nos2a significantly inhibited NO production.
Student’s t-test was used to evaluate the statistical significance between treated fish and untreated controls (* p < 0.05, ** p < 0.01, *** p < 0.001), as
well as the LPS and GO-exposed fish with/without NOS inhibition/suppression (# p < 0.05, ## p < 0.01, ### p < 0.001).
Fig. 4 NO-dependent degradation of GO in vitro. (a) Visual evidence of degradation upon incubation of GO with the peroxynitrite donor, SIN-1 or
PAPA NONOate-X/XO for 5 days. (b) Raman analysis of GO after incubation with SIN-1 and PAPA NONOate-X/XO for 5 days showed almost com-
plete degradation of GO as evidenced by loss of the characteristic D and G bands. (c) Representative TEM images of untreated GO versus GO
exposed to SIN-1 and PAPA NONOate-X/XO for 5 days. Numerous defects in the GO sheets are visible in SIN-1 exposed samples, in particular, as
well as in GO exposed to PAPA NONOate-X/XO. (d) AFM height contrast images of representative GO samples with or without SIN-1 and PAPA
NONOate-X/XO. The surface of pristine GO is flat, with a mean square roughness (MSR) of 0.112 nm and a thickness of 1–2 nm, while in GO sheets
exposed to SIN-1, several defects of lateral sizes ranging from 50 nm to 200 nm appear, which could be attributed to the degradation of GO.
Furthermore, GO incubated with PAPA NONOate-X/XO shows greater roughness (MSR = 1.655 nm) and an increase of the thickness of GO, which
could be due to the aggregation of the degraded smaller flakes of GO.
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ments could be observed. In addition, SIN-1 treatment led to
numerous perforations of the GO sheets, as shown by TEM,
and these defects were also seen by AFM. To confirm that the
two systems were functional, we monitored NO and peroxy-
nitrite production based on real-time chemiluminescence and
fluorescence detection, respectively. PAPA NONOate induced a
robust and stable NO signal, and the addition of X/XO was
able to decrease the NO signal, likely due to the rapid reaction
between NO and the superoxide radicals (Fig. 5a). Additionally,
continuous treatment of GO revealed that PAPA NONOate
alone was able to decrease the optical density of the GO sus-
pensions, indicative of GO degradation, while X/XO alone did
not exert observable effects (Fig. S2a†). Raman analysis con-
firmed these results (Fig. S2b†). On the other hand, the peroxy-
nitrite donor SIN-1 did not generate a NO signal (at 300 µM),
though there was a slight increase when a higher dose
(900 µM) was applied (Fig. 5b). Instead, the fluorescence inten-
sity of DAX-J2 PON Green increased in a time- and dose-depen-
dent manner upon reacting with SIN-1, clearly showing that
peroxynitrite was formed, while PAPA NONOate (an NO donor)
generated a negligible signal (Fig. 5c). Collectively, these
results suggest that the degradation of GO by PAPA NONOate-
X/XO may be attributed to NO, but not to superoxide radicals,
and that the decomposition of SIN-1 produces superoxide and
NO resulting in rapid formation of ONOO−, which ‘digests’
GO. One may ask what the potential advantages or disadvan-
tages would be of NO-driven degradation of GO. One impor-
tant aspect is that NO-driven degradation does not require
direct interaction with the participating enzymes which means
that cellular uptake of the nanomaterial is not required.
Instead, NO released from gastrointestinal cells may diffuse to
the gut lumen and ‘attack’ GO, leading to its degradation. On
the other hand, a possible limitation is that the kinetics of
NO-driven degradation are evidently slower than those of
MPO.4
Only a few attempts have been made to assess the biological
consequences of nanomaterial degradation or the lack thereof.
Kagan et al.21 found that ex vivo degraded CNTs induced less
pulmonary inflammation when aspirated into the lungs of
mice whereas non-degraded CNTs triggered granuloma for-
Fig. 5 Detection of NO and peroxynitrite using in vitro systems. (a) The NO donor, 1-propamine 3-(2-hydroxy-2-nitroso-1-propylhydrazine) (PAPA)
NONOate, elicited a significant NO signal and the introduction of the superoxide-generating system xanthine/xanthine oxidase (X/XO) resulted in a
decrease of the signal, indicative of peroxynitrite generation. (b) SIN-1 triggered a very low NO signal when compared with PAPA NONOate. (c)
SIN-1 generated peroxynitrite in a dose- and time-dependent manner, while no peroxynitrite was observed when adding the NO donor PAPA
NONOate (at 10 mM).
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mation. In a subsequent study, inflammatory and fibrotic
responses to CNTs were aggravated in MPO-deficient mice
when compared to wild-type mice.22 We recently reported that
MPO-degraded GO was non-cytotoxic and did not exert DNA
damage in cultured human lung cells,4 but in vivo responses
were not evaluated in the latter study. Here we asked whether
biodegradation would alter inflammatory responses induced
by GO in the GI tract. To address this, we employed transgenic
zebrafish, Tg(mpx:eGFP), expressing fluorescent GFP under a
neutrophil-specific promoter to visualize neutrophil infiltra-
tion,23 an acknowledged marker of inflammation. As illus-
trated in Fig. 6a, the GFP-positive neutrophils were mostly
located in the blood vessels in control fish. Following GO
exposure, neutrophils were found to infiltrate the GI tract
(Fig. 6a). Interestingly, in zebrafish exposed to GO in the pres-
ence of L-NAME, significantly more neutrophils migrated
towards the GI tract as compared to fish exposed to GO alone
(Fig. 6b and c). However, L-NAME alone had no impact on neu-
trophil migration (Fig. 6c). These results suggest that NO-
dependent degradation of GO which is suppressed by L-NAME
serves to reduce the inflammatory response triggered by
ingested GO. We found that the recruited neutrophils were
mainly located in the lamina propria (beneath the epithelium)
while very few GFP-positive cells infiltrated into the gut lumen
(Fig. S3†). Therefore, direct interactions between neutrophils
and GO seem unlikely.
The fact that the major organ systems are conserved in zeb-
rafish18 provides an opportunity to decipher potential health
effects of nanomaterials in humans. Specifically, zebrafish
may serve as an alternative to mammalian models for the
study of inflammation, as the cellular and humoral machinery
that regulates immune responses is conserved. In the early
stages of development, zebrafish rely on the innate immune
system to protect against infections or injuries. The present
study shows that the presence of GO is ‘sensed’ in the gut
leading zebrafish larvae to mount a response to the offending
agent. However, the implications of the present findings for
other species including humans can only be speculated upon
Fig. 6 Inflammation in the gastro-intestinal tract of zebrafish is enhanced when NO-dependent GO degradation is blocked. (a) The transgenic
zebrafish strain Tg(mpx:eGFP) with GFP-labeled neutrophils was used to visualize the movement of neutrophils. Fluorescence microscopy shows
that GO exposure resulted in the migration of cells to the gut, while inhibition of NOS with L-NAME led to more neutrophil infiltration. The gut is
indicated by the white dashed line. (b) Confocal images of zebrafish larvae after exposure to GO ± L-NAME. (c) Quantification of neutrophils migrated
to the gut. L-NAME alone had no effect on neutrophil migration. The numbers were quantified based on 10 fish per treatment. Student’s t-test was
used to evaluate statistical significance between the treated fish and untreated control fish (* p < 0.05, ** p < 0.01, *** p < 0.001), as well as GO-
exposed fish co-exposed or not to the NOS inhibitor, L-NAME (# p < 0.05, ## p < 0.01, ### p < 0.001).
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at this stage. Indeed, the overall role of NO in inflammation in
mammals remains unresolved as both pro- and anti-inflamma-
tory effects of NO and related nitrogen species have been
reported.24,25 Anti-inflammatory effects of NO in mammals
involve, for instance, inhibition of leucocyte activation and
recruitment by endothelial cell NO.26 It should be noted that
we used both pharmacological and genetic approaches to
inhibit or silence iNOS in the zebrafish model. This, coupled
with our in vitro results, has revealed a role for NO in the
degradation of GO. However, we have not explored the
different cell populations that may potentially produce NO,
though iNOS is known to be expressed in many cell types in
humans. We presumed that NO is generated by gastrointesti-
nal cells in the present model and that NO (produced by
iNOS) together with superoxide radicals (produced by NADPH
oxidase) combined to produce the highly reactive peroxynitrite
anion (ONOO−).
Conclusions
In conclusion, we have shown that GO can be degraded in vitro
and in vivo in an NO-dependent manner. This study is the first
to demonstrate biodegradation of GO in zebrafish.
Furthermore, while many deleterious reactions have been
attributed to peroxynitrite,27 the present results suggest that
this potent oxidant may also contribute to the innate defense
against foreign intrusion insofar as it is shown here to partici-
pate in the degradation of GO. We also found that the degra-
dation of GO reduces the inflammation (evidenced as neutro-
phil infiltration) triggered upon ingestion of GO. These find-
ings shed new light on the biological fate of GO and further
support the view that GO is a biodegradable material.28
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